| Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the … C Théry, KW Witwer, E Aikawa, MJ Alcaraz, JD Anderson, ... Journal of extracellular vesicles 7 (1), 1535750, 2018 | 9679 | 2018 |
| Biological properties of extracellular vesicles and their physiological functions M Yáñez-Mó, PRM Siljander, Z Andreu, A Bedina Zavec, FE Borràs, ... Journal of extracellular vesicles 4 (1), 27066, 2015 | 5638 | 2015 |
| Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies S O'Neill, L O'Driscoll Obesity reviews 16 (1), 1-12, 2015 | 1919 | 2015 |
| Three-dimensional cell culture: the missing link in drug discovery S Breslin, L O’Driscoll Drug discovery today 18 (5-6), 240-249, 2013 | 1607 | 2013 |
| Applying extracellular vesicles based therapeutics in clinical trials–an ISEV position paper T Lener, M Gimona, L Aigner, V Börger, E Buzas, G Camussi, N Chaput, ... Journal of extracellular vesicles 4 (1), 30087, 2015 | 1306 | 2015 |
| Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches JA Welsh, DCI Goberdhan, L O'Driscoll, EI Buzas, C Blenkiron, ... Journal of extracellular vesicles 13 (2), e12404, 2024 | 1083 | 2024 |
| EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research Ev-Track Consortium, J Van Deun, P Mestdagh, P Agostinis, Ö Akay, ... Nature methods 14 (3), 228-232, 2017 | 1083 | 2017 |
| Matrix metalloproteinase expression and production by alveolar macrophages in emphysema GA Finlay, LR O'DRISCOLL, KJ Russell, EM D'ARCY, JB Masterson, ... American journal of respiratory and critical care medicine 156 (1), 240-247, 1997 | 614 | 1997 |
| Inhibiting extracellular vesicles formation and release: a review of EV inhibitors M Catalano, L O’Driscoll Journal of extracellular vesicles 9 (1), 1703244, 2020 | 567 | 2020 |
| Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes C Corcoran, S Rani, K O’Brien, A O’Neill, M Prencipe, R Sheikh, G Webb, ... PloS one 7 (12), e50999, 2012 | 517 | 2012 |
| Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis C Clarke, SF Madden, P Doolan, ST Aherne, H Joyce, L O’driscoll, ... Carcinogenesis 34 (10), 2300-2308, 2013 | 508 | 2013 |
| Evidence-based clinical use of nanoscale extracellular vesicles in nanomedicine S Fais, L O’Driscoll, FE Borras, E Buzas, G Camussi, F Cappello, ... Perspective, 2016 | 487 | 2016 |
| Prognostic importance of survivin in breast cancer SM Kennedy, L O'Driscoll, R Purcell, N Fitz-Simons, EW McDermott, ... British journal of cancer 88 (7), 1077-1083, 2003 | 416 | 2003 |
| The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance S Breslin, L O'Driscoll Oncotarget 7 (29), 45745, 2016 | 347 | 2016 |
| Intracellular and extracellular microRNAs in breast cancer C Corcoran, AM Friel, MJ Duffy, J Crown, L O'Driscoll Clinical chemistry 57 (1), 18-32, 2011 | 295 | 2011 |
| Extracellular vesicles and anti-cancer drug resistance N Mc Namee, L O'Driscoll Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1870 (2), 123-136, 2018 | 270 | 2018 |
| Mesenchymal stem cell derived extracellular vesicles for tissue engineering and regenerative medicine applications D Tsiapalis, L O’Driscoll Cells 9 (4), 991, 2020 | 262 | 2020 |
| Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells K O’Brien, S Rani, C Corcoran, R Wallace, L Hughes, AM Friel, ... European journal of cancer 49 (8), 1845-1859, 2013 | 261 | 2013 |
| Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles KW Witwer, DCI Goberdhan, L O'Driscoll, C Théry, JA Welsh, C Blenkiron, ... Journal of Extracellular Vesicles 10 (14), e12182, 2021 | 258 | 2021 |
| miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity K O'brien, MC Lowry, C Corcoran, VG Martinez, M Daly, S Rani, ... Oncotarget 6 (32), 32774, 2015 | 252 | 2015 |
Claire CorcoranSenior Scientist, AstraZenecaGeverifieerd e-mailadres voor tcd.ie
